Cumberland Pharmaceuticals (CPIX) EBIAT: 2009-2025
Historic EBIAT for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$1.9 million.
- Cumberland Pharmaceuticals' EBIAT fell 26.23% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.38%. This contributed to the annual value of -$6.5 million for FY2024, which is 2.35% down from last year.
- According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' EBIAT is -$1.9 million, which was down 163.12% from -$740,740 recorded in Q2 2025.
- Cumberland Pharmaceuticals' EBIAT's 5-year high stood at $1.3 million during Q1 2025, with a 5-year trough of -$6.3 million in Q4 2023.
- In the last 3 years, Cumberland Pharmaceuticals' EBIAT had a median value of -$1.1 million in 2024 and averaged -$1.3 million.
- Its EBIAT has fluctuated over the past 5 years, first skyrocketed by 173.16% in 2021, then plummeted by 1,112.71% in 2024.
- Over the past 5 years, Cumberland Pharmaceuticals' EBIAT (Quarterly) stood at -$4.4 million in 2021, then skyrocketed by 43.94% to -$2.5 million in 2022, then plummeted by 156.21% to -$6.3 million in 2023, then surged by 69.79% to -$1.9 million in 2024, then fell by 26.23% to -$1.9 million in 2025.
- Its EBIAT was -$1.9 million in Q3 2025, compared to -$740,740 in Q2 2025 and $1.3 million in Q1 2025.